Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cel Sci Corp (CVM)  
$1.48 0.06 (4.23%) as of 4:30 Thu 5/2


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 38,620,000
Market Cap: 57.16(M)
Last Volume: 2,036,333 Avg Vol: 2,030,650
52 Week Range: $1.07 - $3.08
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    AMEX COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CEL-SCI is a clinical-stage biotechnology company focused on research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. Co. is focused on the development of the following product candidates and technologies: Multikine® (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for the potential treatment of certain head and neck cancers; and Ligand Epitope Antigen Presentation System technology, with CEL-4000 as a product candidate under development for the potential treatment of rheumatoid arthritis.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 227
  Page 6 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Prichep Patricia B Senior Vice President   •       –      –    2018-06-29 4 A $0.92 $3,669 D/D 3,988 159,456     -
   Prichep Patricia B Senior Vice President   •       –      –    2018-06-11 4 A $2.80 $882 D/D 315 155,468     -
   Kersten Geert R Chief Executive Officer   •       •      –    2018-06-11 4 A $2.80 $8,823 I/I 3,151 768,738     -
   Kersten Geert R Chief Executive Officer   •       •      –    2018-06-11 4 A $2.80 $9,699 D/D 3,464 765,587     -
   Kersten Geert R CEO   •       •      –    2018-06-11 4 OE $2.29 $249,999 I/I 109,170 762,123     -
   Kersten Geert R CEO   •       •      –    2018-06-11 4 OE $1.69 $250,000 D/D 147,929 652,953     -
   Prichep Patricia B Sr. V.P. Operations   •       –      –    2018-06-11 4 OE $2.29 $25,000 D/D 10,917 155,153     -
   Young Peter R Director   –       •      –    2018-06-04 4 OE $1.75 $4,200 D/D 2,400 16,091     -
   Kersten Geert R Chief Executive Officer   •       •      –    2018-06-01 4 OE $1.75 $25,830 D/D 14,760 505,024     -
   Young Peter R Director   –       •      –    2018-05-01 4 B $2.14 $4,280 D/D 2,000 13,691 2.31     -
   Young Peter R Director   –       •      –    2018-04-27 4 B $2.39 $9,540 D/D 4,000 11,691 2.39     -
   Young Peter R Director   –       •      –    2018-04-16 4 B $1.79 $11,675 D/D 6,500 7,691 2.39     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2018-03-30 4 A $1.41 $3,415 D/D 2,422 16,980     -
   Kersten Geert R Chief Executive Officer   •       •      –    2018-03-30 4 A $1.41 $4,124 D/D 2,925 490,264     -
   Prichep Patricia B Senior Vice President   •       –      –    2018-03-30 4 A $1.41 $3,669 D/D 2,602 144,236     -
   Talor Eyal Chief Scientific Officer   •       –      –    2018-03-30 4 A $1.41 $2,400 D/D 1,702 112,959     -
   Talor Eyal CSO   •       –      –    2018-01-22 4 S $2.06 $13,268 D/D (6,441) 111,257     -
   Talor Eyal CSO   •       –      –    2018-01-17 4 S $2.06 $3,607 D/D (1,751) 117,698     -
   Talor Eyal CSO   •       –      –    2018-01-16 4 S $2.15 $3,670 D/D (1,707) 119,449     -
   Talor Eyal CSO   •       –      –    2018-01-12 4 S $2.15 $217 D/D (101) 121,156     -
   Prichep Patricia B Sr. V.P. Operatioms   •       –      –    2017-12-29 4 A $1.89 $3,668 D/D 1,941 141,634     -
   Talor Eyal Chief Scientific Officer   •       –      –    2017-12-29 4 A $1.89 $2,398 D/D 1,269 121,257     -
   Zimmerman Daniel H Sr. Vice President   •       –      –    2017-12-29 4 A $1.89 $3,415 D/D 1,807 14,558     -
   Kersten Geert R Chief Executive Officer   •       •      –    2017-12-29 4 A $1.89 $3,975 D/D 2,103 487,339     -
   Zimmerman Daniel H Sr. Vice President   •       –      –    2017-09-29 4 A $1.66 $3,416 D/D 2,058 12,751     -

  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed